
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
01
Abcam expands partnership with Genedata to enhance AI-driven antibody development across global sites.
02
Deploy Genedata Biologics to unify antibody data for improved R&D efficiency and collaboration.
03
Implement centralized platform to streamline workflows in antibody sample management and characterization.
04
Support development of approximately 500 new antibodies annually through enhanced data connectivity.
The full story
Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development
Read the story
Next storySalesforce And Snowflake Results Challenge The "SaaS Is Dead" NarrativeMore visual stories Slide 1 of 6